 MALVERN, Pa., Aug. 12, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. Ocugen or the Company NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will deliver a virtual presentation at the H.C. Wainwright 2 nd Annual Ophthalmology Virtual Conference on August 17. 